We are live on ! Find out more
INVA icon

Innoviva

119 hedge funds and large institutions have $724M invested in Innoviva in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

30% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 33

12% more funds holding

Funds holding: 106119 (+13)

30% less call options, than puts

Call options by funds: $1.17M | Put options by funds: $1.66M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

60% less capital invested

Capital invested by funds: $1.82B → $724M (-$1.09B)

Holders
119
Holders Change
+13
Holders Change %
+12.26%
% of All Funds
3.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
24
Increased
43
Reduced
33
Closed
11
Calls
$1.17M
Puts
$1.66M
Net Calls
-$493K
Net Calls Change
-$977K

INVA Hedge Fund Activity: Q3 2015 in Review

119 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2015, worth a combined $724M — down 60% from $1.82B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new INVA positions and 11 closed out — a net gain of 13 holders — while 43 added to existing stakes and 33 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $18.2M. The largest seller was OppenheimerFunds, cutting an estimated $47.1M.

  • 119 institutional investors held Innoviva (INVA) as of Q3 2015, up from 106 in Q2 2015.
  • Funds reported $724M of Innoviva stock for Q3 2015, down 60% quarter-over-quarter.
  • 24 funds opened new Innoviva positions in Q3 2015 and 11 closed out, a net change of +13 holders.
  • The largest Innoviva buyer in Q3 2015 was Armistice Capital, an estimated $18.2M added.
  • The largest Innoviva seller in Q3 2015 was OppenheimerFunds, an estimated $47.1M sold.

Based on aggregated 13F filings for Q3 2015.